ArticleScientific reports2026
Efficacy of Sr
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inclusion of the metal based therapeutic ions into bioactive glasses received potential towards tissue regeneration applications due to their excellent biocompatible, mechanical and wear properties. In the current work, one such configuration is chosen, strontium (Sr) and Copper (Cu) ions based bioactive borosilicate glass system i.e., [Formula: see text] with varying composition of Sr and Cu for 0, 1 and 2 wt.%. The glasses were prepared through melt quench process and the as prepared specimens are characterized for their microstructural, mechanical, tribological, biocompatible and biological investigations. The results were found to appealing with microstructure and crystallographic peaks displaying the presence of extracted natural Silica (Si) and Calcium (Ca) powders. Further the same specimens are characterized for their mechanical strength and it was found to be 55.21MPa compressive strength and lowest specific wear rate overall for CuSr-1 wt.% composition. Being CuSr-1% displaying better mechanical properties, the same samples i.e., Cu, Sr for 1wt.%, were investigated for their biocompatible studies through Simulated Body Fluid immersion protocol. The SBF studies indicate the formation of hydroxyapatite that can be inferred from crystallographic peaks and Fourier Transform Infrared Spectroscopy. The samples were also exposed to antibacterial studies against Escherichia coli (E. coli) and Staphylococcus aureus (S.aureus) and are found to exhibit excellent antibacterial activity. The observed selective antibacterial activity highlights the potential of these bioactive glasses as advanced materials for load-bearing orthopaedic implants and bone tissue engineering scaffolds, where the simultaneous requirements of mechanical robustness and antimicrobial efficacy are critical for clinical success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.